OSL — Oncosil Medical Share News
0.000.00%
Last trade - 00:00- AU$22.24m
- AU$15.78m
- AU$1.82m
Australia Stock Exchange release from ONCOSIL MEDICAL : PRE_NR Ends: 16:47:48
Australia Stock Exchange release from ONCOSIL MEDICAL : Half Yearly Report and Accounts
Australia's OncoSil Medical gains most in 17 months on German institute funding
Australia Stock Exchange release from ONCOSIL MEDICAL : PRE_NR Ends: 09:43:44
Australia Stock Exchange release from ONCOSIL MEDICAL : OncoSil approved for Innovation Funding (NUB) in Germany
Australia Stock Exchange release from ONCOSIL MEDICAL : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from ONCOSIL MEDICAL : PRE_NR Ends: 08:41:00
Australia's Oncosil gains on positive results for cancer treatment device
Australia Stock Exchange release from ONCOSIL MEDICAL : Initial Director's Interest Notice - Prof. Ricky Sharma
Australia Stock Exchange release from ONCOSIL MEDICAL : Jobkeeper Payments Notification
Australia Stock Exchange release from ONCOSIL MEDICAL : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from ONCOSIL MEDICAL : PRE_NR Ends: 09:59:30
Australia Stock Exchange release from ONCOSIL MEDICAL : Change of Director's Interest Notice - Mr Nigel Lange
Australia Stock Exchange release from ONCOSIL MEDICAL : Final Director's Interest Notice - Mr Michael Bassett
Australia Stock Exchange release from ONCOSIL MEDICAL : Final Director's Interest Notice - Dr Chris Roberts
Australia Stock Exchange release from ONCOSIL MEDICAL : Notification regarding unquoted securities - OSL
Australia Stock Exchange release from ONCOSIL MEDICAL : Issue of Performance Rights
Australia Stock Exchange release from ONCOSIL MEDICAL : Final Director's Interest Notice
Australia Stock Exchange release from ONCOSIL MEDICAL : Results of the OncoSil 2021 Annual General Meeting